LAM JENNIFER enters ONKURE THERAPEUTICS, INC. with 15K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/5/2022ACC: 0001209191-22-023348
Officer· VP of Finance & Administration
Since Mar 2022
15K
Baseline shares
100% direct
15K
Direct ownership
1 position
95K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned15K
Total
15K direct15K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15K | Direct |
| Total | 15K | 15K direct |
Derivative Holdings3
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
10K
Shares owned
N/A
Exercise price
4.58
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
50K
Shares owned
N/A
Exercise price
8.66
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
35K
Shares owned
N/A
Exercise price
6.69
Expiration
—
Exercise window
—
Total
Underlying
95K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 4.58 | — | — | 10K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 8.66 | — | — | 50K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 6.69 | — | — | 35K | N/A |
| Total | 95K | 0.00 | ||||